Excerpts

Microbes in C3 and C4, which involve a group of well-known periodontitis pathogens such as Porphyromonas gingivalis , Treponema denticola , Porphyromonas endodontalis , and Filifactor alocis presented an increasing trend from CP to stage IV PDAC patients.

Figure 4 shows that within 10 min of CD31 ligation, there were highly significant phosphorylations of ZAP70, Akt, RelA, and cAbl compared to the IgG istotype controls in synovial DN and CD8 + αβT cells.

In the saliva, microbes in C1 including Fusobacterium mortiferum , Lactiplantibacillus plantarum , and Loigolactobacillus coryniformis presented a decreasing trend from CP to stage IV PDAC patients ( Figure 2C and Supplementary Table S4 ).

However, when genes associated to cell junction or bicellular junction formation (GO:0030054, GO:0070830, and GO:0005911) were considered, we noticed a clear trend toward an induced gene response, including claudin-12, plakophilin 2, and FLRT3 (Figure 4 D).

The injection of 375 pmol [3-NT 61 ]CXCL12 showed a trend of reduced lymphocyte extravasation (median number of 1.4 × 10 3 cells) compared to CXCL12.

This is corroborated by a positive trend between the frequency of circulating T FR and neutralization breadth in HIV infected children and negative trend in the same group between PD1 expression and breadth (Figures S3F,G).

In conclusion, a substantial and statistically highly significant reduction of C5a receptors was observed in NSTEMI patients treated with tocilizumab, and as for C5aR1, the downregulation correlated with attenuated TnT release.

However, the number of IFN-γ+ CD4 T cells showed a trend of increase with NET-EN ( Figure 5A ) and a decrease of TNF-α+CD4 T cells with NET-EN ( Figure 5B ).

Reduction of the mitochondrial membrane potential in BC cells by ATP The immunofluorescence staining results revealed that in MDA-MB231 and MCF7 cells, the ATP group exhibited the most intense green fluorescence and the weakest red fluorescence, indicating a decreasing trend in mitochondrial membrane potential during the early stages of apoptosis.

The FA group mice did not show a significant weight increase, but the Cal/Bms group showed a trend of significant weight loss, as summarized in Figure 5C .

The ribosomal protein transcripts aligned clearly, demonstrating an overall trend as opposed to a cluster-specific phenomenon.

In addition, the MFI shifts depicted a significant MHC-II decrease before and after CpG activation with a decreasing trend for MHCI (Figures 1C,D ).

Additionally, CD160 + cells showed a trend to produce higher amounts of IFNγ compared to the control cells.

The RAND-36 questionnaire results showed a trend toward improved physical function in the intervention group, as compared to the placebo. bLF has been shown to prevent arthritis in experimental animal models ( 48 ).

The PFS rates at 6, 12, and 18 months in the HPL group were 82.1%, 43.4%, and 31.2%, respectively, The PFS rate of the HDL group showed a trend of being superior to the HPL group, but there was still no statistically significant difference.

Also, there is a notable trend of lower analyte release of γδ T cells from the older compared with younger uninfected subjects, and a converse trend of increased analyte secretion with older age within the HIV+ subject group.

Conversely, the percentage of TIGIT+ γδ T cells from the ART-suppressed HIV+ subjects positively and significantly correlated with the secretion of five analytes: sCD137, Granzyme A, Granzyme B, MIP1-β, and CCL20/MIP3-α and showed a positive trend for others such as perforin, TNF-α, and IFN-γ (Figures 4B,C ).

A highly significant increase in mRNA and protein levels of TGFβ receptor II (TβRII) was detected in SSc BM-MSCs as compared to healthy controls.

NK cells of infected Cd47 −/− mice also showed an increasing trend in PD-1 expression level, but significantly less granzyme B level (Figures 5I,J ).

There was a marked trend of increased percentages of IL-10 expressing cells in the PP and MLN of WT mice compared to the Il2 −/− mice (Figures 4K,L ).

Consistent with the above findings, neutrophil-mediated ADCC of SKBR3 cells using afucosylated trastuzumab resulted in a highly significant and prominent (up to ~80–90%) decrease in ADCC when compared to normally fucosylated trastuzumab ( Figure 4A ).

Nebivolol had a trend of decreasing IFN-γ, showed a trend of increasing IL-4, and significantly decreased IL-17A when compared to the control group without treatment and the vehicle control ( Figures 1A–C ).

Induction therapy was similar between the two groups but (in line with what observed in Figure 4 ) there was a strong trend for a higher proportion of patients on ciclosporin in the responder group ( Table 2 ).

We found a higher percentage of H2D b -GP33-41 + CD8 + T cells in NFAT1 KO mice while NFAT1/2 DKO mice showed a trend of reduced frequency and significant decreased total numbers of H2D b -GP33-41 specific CTLs compared to WT controls ( Figures 2A,B , S2B – D ).

Recently, we have seen an increasing trend in the number of positive trials in which XRT is used to treat up to three metastatic sites.